… as a material positive for Sun Pharma, enhancing its negotiation and potential … share from competing JAK inhibitors. Sun Pharma also plans to introduce Leqselvi … with potential market expansions, position Sun Pharma favourably in the pharmaceutical landscape …

… : Shares of firms like TCS, Sun Pharma, Zomato, Tata Steel, GAIL, BHEL … stocks in focus include TCS, Sun Pharma, Bharti Hexacom, Eternal (formerly Zomato … » markets Stocks To Watch: TCS, Sun Pharma, Zomato, Tata Steel, GAIL, BHEL …

Indian benchmark indices settled lower on Wednesday, ahead of TCS earnings and Thursdays' holiday, even as the RBI cut the policy rate by 25 basis points due concerns rising around Trump tariff. BSE Sensex dropped 379.93 points, or 0.51 per cent to …

… ;s trade, shares of TCS, Sun Pharma, Bharti Hexacom, Eternal, Greaves Cotton … investment of Rs 239 crore. Sun Pharma Sun Pharma said the US Court of …

Sun Pharmaceutical Industries Ltd, which has been embroiled in a patent lawsuit in the US since last year over its specialty drug Leqselvi, received a favourable ruling from a court, paving the way for the drug’s launch in America, it said on Thursday.

Sun Pharma successfully removed an injunction … Exchange (NSE) of India, Sun Pharma said that patent litigation with … infringement lawsuit is claiming that Sun Pharma's drug infringes … date – have been redacted. Sun Pharma acquired Leqselvi when it took …

… delayed its entry last fall, Sun Pharma has received the all-clear … treatment available for patients,” a Sun Pharma spokesperson told Fierce Pharma over …

Drugmaker Sun Pharma on Thursday said the U. … in due course of time, Sun Pharma said. On April 9, the …

… ongoing patent litigation between Sun Pharma and Incyte Corporation. Sun Pharma informed the exchanges … with Incyte Corporation continues, Sun Pharma is no longer constrained by … Conference Headquartered in Mumbai, Sun Pharma manufactures and sells a wide …

… ruled in favour of Sun Pharma by removing the … a patent dispute between Sun Pharma and Incyte Corporation. Earlier … compound deuruxolitinib. However, Sun Pharma challenged this order in … favour of Sun Pharma, lifting the previous ban. “Sun Pharma had been …